Our observations suggest that m6A methylation facilitates IGF2BP2 binding to GAS5, enhancing its stability, and confirm significant overexpression of GAS5 in large cohorts of patients with HCC (Fig. 2a). Here, GAS5 is linked to hepatocellular carcinoma.